2.68
+0.05(+1.90%)
Currency In USD
| Previous Close | 2.63 |
| Open | 2.69 |
| Day High | 2.74 |
| Day Low | 2.6 |
| 52-Week High | 6.28 |
| 52-Week Low | 1.91 |
| Volume | 38,142 |
| Average Volume | 122,213 |
| Market Cap | 15.78M |
| PE | -1.21 |
| EPS | -2.22 |
| Moving Average 50 Days | 3.03 |
| Moving Average 200 Days | 3.23 |
| Change | 0.05 |
If you invested $1000 in Vivos Therapeutics, Inc. (VVOS) since IPO date, it would be worth $11.92 as of April 29, 2025 at a share price of $2.68. Whereas If you bought $1000 worth of Vivos Therapeutics, Inc. (VVOS) shares 3 years ago, it would be worth $61.97 as of April 29, 2025 at a share price of $2.68.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Vivos Therapeutics Signs Definitive Agreement to Acquire Largest Sleep Center Operator in Nevada
GlobeNewswire Inc.
Apr 16, 2025 12:30 PM GMT
By acquiring The Sleep Center of Nevada, Vivos expands its business model to make its OSA treatments available to thousands of patients in the greater Las Vegas metro area Acquisition expected to close later this quarter or in the third quarter LITTL
Vivos Therapeutics Schedules Release of Full Year 2024 Financial Results and Conference Call
GlobeNewswire Inc.
Mar 28, 2025 12:30 PM GMT
Call Scheduled for Monday, March 31, 2025 at 5:00 pm ETLITTLETON, Colo., March 28, 2025 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. (“Vivos” or the “Company”) (NASDAQ: VVOS), a leading medical device and technology company specializing in the deve
Vivos Therapeutics Expands Strategic Alliance in Colorado and Seeks New Sleep Center Affiliations and Acquisitions Nationwide
GlobeNewswire Inc.
Feb 24, 2025 1:30 PM GMT
Vivos announces immediate expansion of its new alliance model into two additional Colorado locations as initial reports show sleep apnea patients prefer Vivos CARE treatment for OSA nearly 2 to 1 over CPAP Vivos seeking additional alliances or acquis